CAeditome Logo

Home

Download

Statistics

Landscape

Help

Contact
Center for Computational Systems Medicine
Soverview

1. Gene summary of enriched editing regions

Soverview

2. Tumor-specific enriched editing regions

Comparison of enriched editing regions between tumor and normal.

Correlation of enriched editing regions with tumor stages.

Associations of enriched editing regions with cancer survival.

Soverview

3. Enriched editing regions and immune related genes

Soverview

4. Enriched editing regions and immune related splicing

Soverview

5. Enriched editing regions and immune infiltration

Soverview

6. Enriched editing regions and immune gene sets

Correlation of enriched editing regions with epithelial-mesenchymal transition.

Correlations of enriched editing regions with hypoxic.

Associations of enriched editing regions with hallmark gene sets from MSigDB.

Soverview

7. Enriched editing regions and drugs

Correlations between enriched editing regions and drug sensitivity.

Enriched editing regions targeted by drugs from DrugBank database.

Editing gene: SLC25A25-AS1 (ImmuneEditome ID:100289019)

1. Gene summary of enriched editing regions for SLC25A25-AS1

check button Gene summary
Gene informationGene symbol

SLC25A25-AS1

Gene ID

100289019

GeneSynonymsHRCEG
GeneCytomap

9q34.11

GeneTypencRNA
GeneDescriptionHDAC1 regulated RNA affecting cell proliferation and EMT transition in gastric cancer
GeneModificationdate20230329
UniprotID.
PubMed ID

check buttonUCSC image.
all structure

check buttonLocations of each EERs.
EERENSTENSGGeneNameRegionRepeatdsRNA structure
chr9:128110396-128113293:-ENST00000418747.2ENSG00000234771.3SLC25A25-AS1ncRNA_exonicAluSx,AluJr,AluSq2,L1ME2,AluSc8,AluSx1chr9:128110396-128113293:-.alignment


Top

2. Tumor-specific enriched editing regions for SLC25A25-AS1


all structure

check buttonComparison of enriched editing regions between tumor and normal.
* P<0.05 and Informative number >=20.
* EER: enriched editing region, EAG: EER-associated genes.
ID_eventscancerTypePBoxplot
chr9:128110396-128113293:-COADEER6.7197e-28image
ENSG00000234771.3,SLC25A25-AS1COADEAG6.7197e-28image
chr9:128110396-128113293:-KICHEER7.4223e-03image
ENSG00000234771.3,SLC25A25-AS1KICHEAG7.4223e-03image
chr9:128110396-128113293:-KIRCEER2.2120e-03image
ENSG00000234771.3,SLC25A25-AS1KIRCEAG2.2120e-03image
chr9:128110396-128113293:-KIRPEER2.7504e-03image
ENSG00000234771.3,SLC25A25-AS1KIRPEAG2.7504e-03image


Top

check buttonCorrelation of enriched editing regions with tumor stages.
* AnovaP<0.05, Pearson P<0.05 and Informative number >=20.
* EER: enriched editing region, EAG: EER-associated genes, Path: Pathological stage, Cli: Clinical stage.
* Only shows the most significant correlation result of EERs/EAGs with either pathological stage or clinical stage according to correlation coefficient (R). For more results, please go to download page.
ID_eventscancerTypeStageTypeAnovaPPRBoxplot
ENSG00000234771.3,SLC25A25-AS1HNSCCliEAG5.1614e-042.2403e-02-0.4299image


Top

check button Associations of enriched editing regions with cancer survival.
* Pkm<0.05 and Pcox<0.05.
* EER: enriched editing region, EAG: EER-associated genes.
ID_eventscancerTypeIDPkmPcox_continuousHR_continuousKMPlot
chr9:128110396-128113293:-UCSEER3.8748e-022.6202e-024.7911e+03image
ENSG00000234771.3,SLC25A25-AS1UCSEAG3.8748e-022.6202e-024.7911e+03image

Top

3. Enriched editing regions and immune related genes for SLC25A25-AS1


all structure

check button Enriched editing regions and immune related genes.
* First, the associations between enriched editing regions and genes were tested by QTL and Pearson method (QTL: FDR<0.05 and Pearson: P<0.05).
* Second, the gene relationships with immune were tested by three analyses: whether the gene is an immune gene (InnateDB、Immport、Immunome、Immunogenetic Related Information Source (IRIS)), whether the gene is associated with immune infiltration and whether the gene is related to immune gene sets.
* EER: enriched editing region, EAG: EER-associated genes.
* Only shows the most significant correlation result of genes with the fraction of different immune cells and the scores of 50 hallmark genesets according to correlation coefficient (R). For more results, please go to download page.
ID_eventscancerTypeGenebetaFDRPearsonPPearsonRCorrelationPlotRBPRBPtargetsImmuneGeneImmuneFractionHallMark
chr9:128110396-128113293:-KICHEERENSG00000116954,RRAGC0.58233.3447e-021.6490e-050.5413imageNAUH;BUD13;CELF2;CNBP;CPSF6;CSTF2T;DDX54;DGCR8;DHX9;EIF4A3;EIF4G2;ELAVL1;FAM120A;FBL;FMR1;FUS;FXR1;FXR2;HNRNPA1;HNRNPA2B1;HNRNPC;HNRNPUL1;IGF2BP1;IGF2BP2;IGF2BP3;LIN28;LIN28B;MOV10;NOP56;NOP58;PRPF8;PTBP1;RANGAP1;RBM10;RBM22;SAFB2;SMNDC1;SND1;SRSF1;SRSF10;SRSF7;SRSF9;TAF15;TARDBP;TIA1;TNRC6A;TRA2A;TROVE2;U2AF1;U2AF2;UPF1;XRN2;YTHDF1;ZNF184RRAGCMast_cells_activatedGSVA_HALLMARK_P53_PATHWAY
chr9:128110396-128113293:-KICHEERENSG00000153574,RPIA0.56543.7689e-022.9582e-050.5274imageNAUH;BUD13;CELF2;CNBP;CPSF6;CSTF2T;DDX54;DGCR8;DHX9;DKC1;EIF4A3;EIF4G2;ELAVL1;FAM120A;FBL;FMR1;FUS;FXR1;FXR2;HNRNPA1;HNRNPA2B1;HNRNPC;IGF2BP1;IGF2BP2;IGF2BP3;LIN28;LIN28B;MOV10;NOP56;NOP58;PRPF8;PTBP1;RANGAP1;RBFOX2;RBM10;SF3B4;SMNDC1;SND1;SRSF1;SRSF7;SRSF9;TAF15;TARDBP;TIA1;U2AF1;U2AF2;UPF1;XRN2NAT_cells_CD4_memory_activatedGSVA_HALLMARK_IL6_JAK_STAT3_SIGNALING
chr9:128110396-128113293:-KICHEERENSG00000166579,NDEL10.55234.5723e-021.0116e-030.4276imageNAUH;BUD13;CELF2;CNBP;CPSF6;CSTF2T;DDX54;DGCR8;DHX9;DKC1;EIF4A3;EIF4G2;ELAVL1;FAM120A;FBL;FMR1;FUS;FXR1;FXR2;HNRNPA1;HNRNPA2B1;HNRNPC;HNRNPUL1;IGF2BP1;IGF2BP2;IGF2BP3;LIN28;LIN28B;MOV10;NOP56;NOP58;PRPF8;PTBP1;RANGAP1;RBFOX2;RBM10;RBM22;SAFB2;SF3B4;SLBP;SMNDC1;SND1;SRSF1;SRSF10;SRSF7;SRSF9;TAF15;TARDBP;TIA1;TNRC6A;TRA2A;TROVE2;U2AF1;U2AF2;UPF1;XRN2;YTHDF1;ZNF184NAMast_cells_restingGSVA_HALLMARK_TNFA_SIGNALING_VIA_NFKB
chr9:128110396-128113293:-KICHEERENSG00000100439,ABHD40.54424.6357e-023.0354e-070.6224imageNAUH;BUD13;CELF2;CNBP;CPSF6;CSTF2T;DDX54;DGCR8;EIF4A3;EIF4G2;ELAVL1;FAM120A;FBL;FMR1;FUS;FXR1;FXR2;HNRNPA1;HNRNPA2B1;HNRNPC;HNRNPUL1;IGF2BP1;IGF2BP2;IGF2BP3;LIN28;LIN28B;MOV10;NOP58;PRPF8;PTBP1;RANGAP1;RBFOX2;RBM22;SAFB2;SF3B4;SMNDC1;SND1;SRSF1;SRSF10;SRSF7;SRSF9;TAF15;TARDBP;TIA1;TNRC6A;TRA2A;TROVE2;U2AF1;U2AF2;UPF1;XRN2;YTHDF1NAB_cells_memoryGSVA_HALLMARK_P53_PATHWAY
chr9:128110396-128113293:-KICHEERENSG00000248593,DSTNP20.55874.6687e-024.1236e-060.5720imageNNNAMonocytesGSVA_HALLMARK_P53_PATHWAY

More results



Top

4. Enriched editing regions and immune related splicing for SLC25A25-AS1


all structure

check button Enriched editing regions and immune related splicing.
* First, the associations between enriched editing regions and splicing events were tested by QTL and Pearson method (QTL: FDR<0.05 and Pearson: P<0.05).
* Second, the splicing relationships with immune were tested by three analyses: whether the splicing event locates in an immune gene (InnateDB、Immport, Immunome and Immunogenetic Related Information Source (IRIS)), whether the splicing event is associated with immune infiltration and whether the splicing event is related to immune gene sets.
* EER: enriched editing region, EAG: EER-associated genes.
* Only shows the most significant correlation result of splicing events with the fraction of different immune cells and the scores of 50 hallmark genesets according to correlation coefficient (R). For more results, please go to download page.
ID_eventscancerTypeSplicingTypeSplicingGeneSplicingChrSplicingPositionbetaFDRPearsonPPearsonRCorrelationPlotRBPRBPtargetsImmuneGeneImmuneFractionHallMark

More results



Top

5. Enriched editing regions and immune infiltration for SLC25A25-AS1


all structure

check button Associations of enriched editing regions with immune infiltration.
* P<0.05 and Informative number >=20.
* EER: enriched editing region, EAG: EER-associated genes.
* Only shows the most significant correlation result of EERs/EAGs with the fraction of different immune cells according to correlation coefficient (R). For more results, please go to download page.
ID_eventscancerTypeIDImmuneCellPRCorrelationPlot
chr9:128110396-128113293:-BLCAEERT_cells_follicular_helper2.0146e-02-0.2715image
ENSG00000234771.3,SLC25A25-AS1BLCAEAGT_cells_follicular_helper2.0146e-02-0.2715image
chr9:128110396-128113293:-BRCAEERT_cells_CD81.7068e-02-0.1766image
ENSG00000234771.3,SLC25A25-AS1BRCAEAGT_cells_CD81.7068e-02-0.1766image
chr9:128110396-128113293:-CHOLEERNeutrophils9.2795e-030.5095image
ENSG00000234771.3,SLC25A25-AS1CHOLEAGNeutrophils9.2795e-030.5095image
chr9:128110396-128113293:-COADEERMacrophages_M12.9843e-050.2806image
ENSG00000234771.3,SLC25A25-AS1COADEAGMacrophages_M12.9843e-050.2806image
chr9:128110396-128113293:-ESCAEERT_cells_CD4_memory_activated1.7853e-030.3013image
ENSG00000234771.3,SLC25A25-AS1ESCAEAGT_cells_CD4_memory_activated1.7853e-030.3013image
chr9:128110396-128113293:-GBMEERT_cells_regulatory_(Tregs)4.4620e-020.2602image
ENSG00000234771.3,SLC25A25-AS1GBMEAGT_cells_regulatory_(Tregs)4.4620e-020.2602image
chr9:128110396-128113293:-KICHEERB_cells_memory1.8523e-070.6310image
ENSG00000234771.3,SLC25A25-AS1KICHEAGB_cells_memory1.8523e-070.6310image
chr9:128110396-128113293:-KIRCEERB_cells_naive4.4457e-020.2112image
ENSG00000234771.3,SLC25A25-AS1KIRCEAGB_cells_naive4.4457e-020.2112image
chr9:128110396-128113293:-KIRPEERT_cells_CD4_memory_activated3.6291e-020.2036image
ENSG00000234771.3,SLC25A25-AS1KIRPEAGT_cells_CD4_memory_activated3.6291e-020.2036image
chr9:128110396-128113293:-LGGEERNeutrophils3.2683e-020.1868image
ENSG00000234771.3,SLC25A25-AS1LGGEAGNeutrophils3.2683e-020.1868image
chr9:128110396-128113293:-LIHCEERT_cells_gamma_delta2.1896e-02-0.2136image
ENSG00000234771.3,SLC25A25-AS1LIHCEAGT_cells_gamma_delta2.1896e-02-0.2136image
chr9:128110396-128113293:-LUSCEERNK_cells_resting2.6104e-030.2856image
ENSG00000234771.3,SLC25A25-AS1LUSCEAGNK_cells_resting2.6104e-030.2856image
chr9:128110396-128113293:-OVEERDendritic_cells_resting8.8373e-040.2375image
ENSG00000234771.3,SLC25A25-AS1OVEAGDendritic_cells_resting8.6981e-040.2378image
chr9:128110396-128113293:-PAADEERT_cells_gamma_delta3.8610e-020.1899image
ENSG00000234771.3,SLC25A25-AS1PAADEAGT_cells_gamma_delta3.8610e-020.1899image
chr9:128110396-128113293:-PCPGEERT_cells_CD4_memory_resting4.7221e-020.2594image
ENSG00000234771.3,SLC25A25-AS1PCPGEAGT_cells_CD4_memory_resting4.7221e-020.2594image
chr9:128110396-128113293:-PRADEERMacrophages_M04.1475e-030.4024image
ENSG00000234771.3,SLC25A25-AS1PRADEAGMacrophages_M04.1475e-030.4024image
chr9:128110396-128113293:-READEERDendritic_cells_activated4.9126e-02-0.2265image
ENSG00000234771.3,SLC25A25-AS1READEAGDendritic_cells_activated4.9126e-02-0.2265image
chr9:128110396-128113293:-STADEERT_cells_CD4_memory_resting6.9832e-04-0.1874image
ENSG00000234771.3,SLC25A25-AS1STADEAGT_cells_CD4_memory_resting6.0764e-04-0.1892image
ENSG00000234771.3,SLC25A25-AS1TGCTEAGB_cells_memory2.9127e-02-0.3986image
chr9:128110396-128113293:-THYMEERMacrophages_M16.7931e-030.3641image
ENSG00000234771.3,SLC25A25-AS1THYMEAGMacrophages_M16.7931e-030.3641image
chr9:128110396-128113293:-UCECEERDendritic_cells_activated7.2418e-030.3790image
ENSG00000234771.3,SLC25A25-AS1UCECEAGDendritic_cells_activated7.2418e-030.3790image


Top

6. Enriched editing regions and immune gene sets for SLC25A25-AS1


all structure

check button Correlation of enriched editing regions with epithelial-mesenchymal transition.
* First, the differences of enriched editing regions between Epi and Mes groups (defined by KS-test) were compared (P<0.05 and Informative number >=20).
* Second, the correlations between enriched editing regions and gene set score of HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION were analyzed (P<0.05 and Informative number >=20).
* EER: enriched editing region, EAG: EER-associated genes.
* Only shows the EERs/EAGs significantly edited between Epi and Mes group.
ID_eventscancerTypeE2M_PBoxplotCorPCorRCorrelationPlot


Top

check button Correlations of enriched editing regions with hypoxic.
* First, there are four hypoxia scores used in the database. The first three hypoxic scores were calculated on three gene sets of Buffa, Ragnum and Winter based on one previous study (PMID: 32024819). One last hypoxia score was defined on HALLMARK_HYPOXIA by GSVA method.
* Second, the correlations enriched editing regions with the four hypoxic scores were analyzed (P<0.05 and Informative number >=20).
* EER: enriched editing region, EAG: EER-associated genes.
* Only shows the EERs/EAGs significantly correlated with all four hypoxia gene set scores. For more results, please go to download page.
ID_eventscancerTypeBuffa_P Buffa_R Ragnum_P Ragnum_R Winter_P Winter_R HALLMARK_P HALLMARK_R CorrelationPlot


Top

check button Associations of enriched editing regions with hallmark gene sets from MSigDB.
* P<0.05 and Informative number >=20.
* EER: enriched editing region, EAG: EER-associated genes.
* Only shows the most significant correlation result of EERs/EAGs with the scores of 50 hallmark genesets according to correlation coefficient (R). For more results, please go to download page.
ID_eventscancerHallmarkTypeTypePRCorrelationPlot
chr9:128110396-128113293:-BLCAGSVA_HALLMARK_PI3K_AKT_MTOR_SIGNALINGEER3.3014e-020.2499image
ENSG00000234771.3,SLC25A25-AS1BLCAGSVA_HALLMARK_PI3K_AKT_MTOR_SIGNALINGEAG3.3014e-020.2499image
chr9:128110396-128113293:-BRCAGSVA_HALLMARK_TGF_BETA_SIGNALINGEER1.0542e-040.2835image
ENSG00000234771.3,SLC25A25-AS1BRCAGSVA_HALLMARK_TGF_BETA_SIGNALINGEAG1.0542e-040.2835image
ENSG00000234771.3,SLC25A25-AS1CESCGSVA_HALLMARK_MITOTIC_SPINDLEEAG3.8539e-030.3139image
chr9:128110396-128113293:-CESCGSVA_HALLMARK_MITOTIC_SPINDLEEER3.8539e-030.3139image
chr9:128110396-128113293:-CHOLGSVA_HALLMARK_MTORC1_SIGNALINGEER1.4051e-020.4848image
ENSG00000234771.3,SLC25A25-AS1CHOLGSVA_HALLMARK_MTORC1_SIGNALINGEAG1.4051e-020.4848image
chr9:128110396-128113293:-COADGSVA_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITIONEER4.7319e-040.2364image
ENSG00000234771.3,SLC25A25-AS1COADGSVA_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITIONEAG4.7319e-040.2364image
ENSG00000234771.3,SLC25A25-AS1ESCAGSVA_HALLMARK_BILE_ACID_METABOLISMEAG1.3088e-03-0.3096image
chr9:128110396-128113293:-ESCAGSVA_HALLMARK_BILE_ACID_METABOLISMEER1.3088e-03-0.3096image
ENSG00000234771.3,SLC25A25-AS1GBMGSVA_HALLMARK_HEDGEHOG_SIGNALINGEAG1.2915e-020.3192image
chr9:128110396-128113293:-GBMGSVA_HALLMARK_HEDGEHOG_SIGNALINGEER1.2915e-020.3192image
ENSG00000234771.3,SLC25A25-AS1HNSCGSVA_HALLMARK_MYOGENESISEAG1.6120e-030.5681image
ENSG00000234771.3,SLC25A25-AS1KIRCGSVA_HALLMARK_ANGIOGENESISEAG8.8041e-040.3428image
chr9:128110396-128113293:-KIRCGSVA_HALLMARK_ANGIOGENESISEER8.8041e-040.3428image
chr9:128110396-128113293:-KIRPGSVA_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITIONEER1.0093e-030.3149image
ENSG00000234771.3,SLC25A25-AS1KIRPGSVA_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITIONEAG1.0093e-030.3149image
ENSG00000234771.3,SLC25A25-AS1LAMLGSVA_HALLMARK_HEDGEHOG_SIGNALINGEAG3.6506e-02-0.3548image
chr9:128110396-128113293:-LGGGSVA_HALLMARK_PANCREAS_BETA_CELLSEER1.1463e-03-0.2811image
ENSG00000234771.3,SLC25A25-AS1LGGGSVA_HALLMARK_PANCREAS_BETA_CELLSEAG1.1463e-03-0.2811image
chr9:128110396-128113293:-LIHCGSVA_HALLMARK_MTORC1_SIGNALINGEER5.2276e-030.2588image
ENSG00000234771.3,SLC25A25-AS1LIHCGSVA_HALLMARK_MTORC1_SIGNALINGEAG5.2276e-030.2588image
ENSG00000234771.3,SLC25A25-AS1LUADGSVA_HALLMARK_XENOBIOTIC_METABOLISMEAG1.5985e-03-0.3132image
chr9:128110396-128113293:-LUADGSVA_HALLMARK_XENOBIOTIC_METABOLISMEER1.5985e-03-0.3132image
chr9:128110396-128113293:-OVGSVA_HALLMARK_PROTEIN_SECRETIONEER2.8691e-020.1575image
ENSG00000234771.3,SLC25A25-AS1OVGSVA_HALLMARK_PROTEIN_SECRETIONEAG2.7582e-020.1586image
chr9:128110396-128113293:-PAADGSVA_HALLMARK_DNA_REPAIREER1.1549e-02-0.2308image
ENSG00000234771.3,SLC25A25-AS1PAADGSVA_HALLMARK_DNA_REPAIREAG1.1549e-02-0.2308image
chr9:128110396-128113293:-PCPGGSVA_HALLMARK_G2M_CHECKPOINTEER3.2900e-030.3765image
ENSG00000234771.3,SLC25A25-AS1PCPGGSVA_HALLMARK_G2M_CHECKPOINTEAG3.2900e-030.3765image
chr9:128110396-128113293:-PRADGSVA_HALLMARK_MITOTIC_SPINDLEEER3.4919e-030.4094image
ENSG00000234771.3,SLC25A25-AS1PRADGSVA_HALLMARK_MITOTIC_SPINDLEEAG3.4919e-030.4094image
chr9:128110396-128113293:-READGSVA_HALLMARK_BILE_ACID_METABOLISMEER4.7381e-020.2282image
ENSG00000234771.3,SLC25A25-AS1READGSVA_HALLMARK_BILE_ACID_METABOLISMEAG4.7381e-020.2282image
chr9:128110396-128113293:-STADGSVA_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITIONEER7.2531e-040.1868image
ENSG00000234771.3,SLC25A25-AS1STADGSVA_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITIONEAG6.6331e-040.1879image
ENSG00000234771.3,SLC25A25-AS1TGCTGSVA_HALLMARK_WNT_BETA_CATENIN_SIGNALINGEAG1.1941e-020.4530image
chr9:128110396-128113293:-THCAGSVA_HALLMARK_UNFOLDED_PROTEIN_RESPONSEEER4.9566e-030.2414image
ENSG00000234771.3,SLC25A25-AS1THCAGSVA_HALLMARK_UNFOLDED_PROTEIN_RESPONSEEAG4.9566e-030.2414image
ENSG00000234771.3,SLC25A25-AS1THYMGSVA_HALLMARK_TGF_BETA_SIGNALINGEAG4.1154e-030.3843image
chr9:128110396-128113293:-THYMGSVA_HALLMARK_TGF_BETA_SIGNALINGEER4.1154e-030.3843image


Top

7. Enriched editing regions and drugs for SLC25A25-AS1


all structure

check button Correlations between enriched editing regions and drug sensitivity.
* First, the drug sensitivity (IS50) was estimated on 84 drugs by pRRophetic package.
* Second, the correlations between editing enriched regions and drug sensitivity were analyzed (P<0.05 and Informative number >=20).
* EER: enriched editing region, EAG: EER-associated genes.
* Only shows the most significant correlation result of EERs/EAGs with the IS50 scores of 84 drugs according to correlation coefficient (R). For more results, please go to download page.
ID_eventscancerDrugTypePRCorrelationPlot
ENSG00000234771.3,SLC25A25-AS1BLCAMethotrexateEAG1.5429e-02-0.2826image
chr9:128110396-128113293:-BLCAMethotrexateEER1.5429e-02-0.2826image
ENSG00000234771.3,SLC25A25-AS1BRCAGDC.0449EAG1.5930e-030.2324image
chr9:128110396-128113293:-BRCAGDC.0449EER1.5930e-030.2324image
ENSG00000234771.3,SLC25A25-AS1CESCBAY.61.3606EAG4.5322e-04-0.3764image
chr9:128110396-128113293:-CESCBAY.61.3606EER4.5322e-04-0.3764image
chr9:128110396-128113293:-COADJNJ.26854165EER1.8573e-05-0.2875image
ENSG00000234771.3,SLC25A25-AS1COADJNJ.26854165EAG1.8573e-05-0.2875image
chr9:128110396-128113293:-ESCAJNJ.26854165EER2.5534e-07-0.4798image
ENSG00000234771.3,SLC25A25-AS1ESCAJNJ.26854165EAG2.5534e-07-0.4798image
ENSG00000234771.3,SLC25A25-AS1GBMBIBW2992EAG1.2694e-020.3200image
chr9:128110396-128113293:-GBMBIBW2992EER1.2694e-020.3200image
ENSG00000234771.3,SLC25A25-AS1HNSCCytarabineEAG3.6308e-030.5312image
chr9:128110396-128113293:-KICHA.443654EER2.9678e-040.4658image
ENSG00000234771.3,SLC25A25-AS1KICHA.443654EAG2.9678e-040.4658image
ENSG00000234771.3,SLC25A25-AS1KIRCCHIR.99021EAG4.1086e-04-0.3627image
chr9:128110396-128113293:-KIRCCHIR.99021EER4.1086e-04-0.3627image
chr9:128110396-128113293:-KIRPAP.24534EER4.8334e-04-0.3332image
ENSG00000234771.3,SLC25A25-AS1KIRPAP.24534EAG4.8334e-04-0.3332image
ENSG00000234771.3,SLC25A25-AS1LGGAP.24534EAG3.7647e-03-0.2515image
chr9:128110396-128113293:-LGGAP.24534EER3.7647e-03-0.2515image
chr9:128110396-128113293:-LIHCMG.132EER4.1607e-030.2736image
ENSG00000234771.3,SLC25A25-AS1LIHCMG.132EAG4.1607e-030.2736image
chr9:128110396-128113293:-LUADBexaroteneEER6.9836e-030.2695image
ENSG00000234771.3,SLC25A25-AS1LUADBexaroteneEAG6.9836e-030.2695image
ENSG00000234771.3,SLC25A25-AS1LUSCBosutinibEAG2.2658e-02-0.2182image
chr9:128110396-128113293:-LUSCBosutinibEER2.2658e-02-0.2182image
ENSG00000234771.3,SLC25A25-AS1OVKU.55933EAG1.0889e-02-0.1829image
chr9:128110396-128113293:-OVKU.55933EER1.1121e-02-0.1824image
chr9:128110396-128113293:-PAADAP.24534EER1.2446e-04-0.3446image
ENSG00000234771.3,SLC25A25-AS1PAADAP.24534EAG1.2446e-04-0.3446image
chr9:128110396-128113293:-PCPGCI.1040EER1.4315e-030.4057image
ENSG00000234771.3,SLC25A25-AS1PCPGCI.1040EAG1.4315e-030.4057image
chr9:128110396-128113293:-PRADLenalidomideEER1.9298e-03-0.4322image
ENSG00000234771.3,SLC25A25-AS1PRADLenalidomideEAG1.9298e-03-0.4322image
chr9:128110396-128113293:-READMidostaurinEER7.2906e-03-0.3055image
ENSG00000234771.3,SLC25A25-AS1READMidostaurinEAG7.2906e-03-0.3055image
ENSG00000234771.3,SLC25A25-AS1STADA.770041EAG3.5205e-07-0.2780image
chr9:128110396-128113293:-STADA.770041EER3.1959e-07-0.2794image
ENSG00000234771.3,SLC25A25-AS1TGCTDocetaxelEAG9.2155e-03-0.4674image
ENSG00000234771.3,SLC25A25-AS1THCAAMG.706EAG2.7871e-020.1900image
chr9:128110396-128113293:-THCAAMG.706EER2.7871e-020.1900image
ENSG00000234771.3,SLC25A25-AS1THYMAS601245EAG4.9049e-03-0.3774image
chr9:128110396-128113293:-THYMAS601245EER4.9049e-03-0.3774image
ENSG00000234771.3,SLC25A25-AS1UCECCamptothecinEAG1.8522e-020.3353image
chr9:128110396-128113293:-UCECCamptothecinEER1.8522e-020.3353image


Top

check button EAGs targeted by drugs from DrugBank database.
* EAG: EER-associated genes.
EERENSTUniprotIDDrugBankIDDrugDrugType